{"product_id":"evidencebased-pediatric-oncology-evidencebased-medicine-9780470659649","title":"EvidenceBased Pediatric Oncology EvidenceBased","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eThis book is updated with evidence from the latest published reviews and is more clinically focused, with an emphasis on application of the trial findings.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eList of contributors, vii\u003c\/p\u003e \u003cp\u003ePreface, ix\u003c\/p\u003e \u003cp\u003eList of abbreviations, x\u003c\/p\u003e \u003cp\u003eAbout the companion website, xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Solid tumors\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Rhabdomyosarcoma, 3\u003cbr\u003e\u003ci\u003eKatherine K. Matthay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Meriel Jenney)\u003c\/p\u003e \u003cp\u003e2 Osteosarcoma, 14\u003cbr\u003e\u003ci\u003eKatherine K. Matthay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Maria Michelagnoli)\u003c\/p\u003e \u003cp\u003e3 Ewing sarcoma, 25\u003cbr\u003e\u003ci\u003eKatherine K. Matthay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Steven G. DuBois)\u003c\/p\u003e \u003cp\u003e4 Wilms tumor, 34\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Kathy Pritchard-Jones)\u003c\/p\u003e \u003cp\u003e5 Neuroblastoma, 47\u003cbr\u003e\u003ci\u003eKatherine K. Matthay\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Katherine K. Matthay)\u003c\/p\u003e \u003cp\u003e6 Hepatoblastoma, 58\u003cbr\u003e\u003ci\u003eRoss Pinkerton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Penelope Brock)\u003c\/p\u003e \u003cp\u003e7 Malignant germ cell tumors, 65\u003cbr\u003e\u003ci\u003eRoss Pinkerton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Ross Pinkerton)\u003c\/p\u003e \u003cp\u003e8 Medulloblastoma, 69\u003cbr\u003e\u003ci\u003eRoss Pinkerton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Eric Bouffet)\u003c\/p\u003e \u003cp\u003e9 Glioma, 81\u003cbr\u003e\u003ci\u003eRoss Pinkerton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Joann L. Ater)\u003c\/p\u003e \u003cp\u003e10 Non-Hodgkin lymphoma, 88\u003cbr\u003e\u003ci\u003eRoss Pinkerton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Ross Pinkerton)\u003c\/p\u003e \u003cp\u003e11 Hodgkin lymphoma, 105\u003cbr\u003e\u003ci\u003eRoss Pinkerton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Cindy L. Schwartz)\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Leukemia\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1: Acute myeloid leukemia 12 Acute myeloid leukemia commentary, 119\u003c\/b\u003e\u003cbr\u003e\u003ci\u003eRobert J. Arceci\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Remission induction in acute myeloid leukemia, 126\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Acute myeloid leukemia consolidation, 135\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Maintenance treatment in acute myeloid leukemia, 137\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Autologous bone marrow transplantation in acute myeloid leukemia, 141\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Acute myeloid leukemia: miscellaneous, 144\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2: Childhood lymphoblastic leukemia\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e18 Childhood lymphoblastic leukemia commentary, 146\u003cbr\u003e\u003ci\u003eVaskar Saha\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Remission induction in childhood lymphoblastic leukemia, 154\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Central nervous system-directed therapy in childhood lymphoblastic leukemia, 168\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Maintenance treatment in childhood lymphoblastic leukemia, 180\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Relapsed childhood lymphoblastic leukemia, 198\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Postinduction therapy in adolescents and young adults with acute lymphoblastic leukemia, 204\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3: Supportive care in pediatric oncology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e24 Colony-stimulating factors, 209\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Victoria Grandage)\u003c\/p\u003e \u003cp\u003e25 Cardioprotection in pediatric oncology, 230\u003cbr\u003e\u003ci\u003eAnanth Shankar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Gill A. Levitt)\u003c\/p\u003e \u003cp\u003e26 Infections in pediatric and adolescent oncology, 243\u003cbr\u003e\u003ci\u003eAnanth Shankar and Sara Stoneham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e(Commentary by Julia E. Clark)\u003c\/p\u003e \u003cp\u003eIndex, 269\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49402394640727,"sku":"9780470659649","price":100.76,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470659649.jpg?v=1730480267","url":"https:\/\/bookcurl.com\/products\/evidencebased-pediatric-oncology-evidencebased-medicine-9780470659649","provider":"Book Curl","version":"1.0","type":"link"}